false
OasisLMS
Catalog
SCCM Resource Library
Choosing the Right Drug
Choosing the Right Drug
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video discusses the topic of pharmacotherapy for pulmonary arterial hypertension (PAH) in critically ill patients. The presenter focuses on how to manage PAH patients who are already on multiple medications and are admitted to the ICU. The different classes of drugs used to treat PAH include prostacyclin pathway drugs, endothelin pathway drugs, and nitric oxide pathway drugs. The prostacyclin pathway drugs increase prostacyclin levels, which helps with vasodilation and antiproliferation. The endothelin pathway drugs target endothelin receptors to prevent vasoconstriction. The nitric oxide pathway drugs help increase nitric oxide levels, which leads to vasodilation. The presenter discusses different strategies for managing PAH medications in the ICU, including converting subcutaneous prostacyclin drugs to intravenous ones, administering inhaled pulmonary vasodilators, and transitioning oral medications to different routes. The video concludes by summarizing the various strategies available to healthcare providers for managing PAH medications in critically ill patients.
Asset Subtitle
Pharmacology, 2023
Asset Caption
Type: one-hour concurrent | The People's Ventricle (SessionID 1333302)
Meta Tag
Content Type
Presentation
Knowledge Area
Pharmacology
Membership Level
Professional
Membership Level
Select
Tag
Pharmacology
Year
2023
Keywords
pharmacotherapy
pulmonary arterial hypertension
critically ill patients
ICU
prostacyclin pathway drugs
endothelin pathway drugs
×
Please select your language
1
English